May 25th, 2023 (Shanghai) — We are glad to announce that Robert E. Claar, the CEO of HekaBio, has been invited as a keynote speaker at ACCESS CHINA Boston Forum on June 4th. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
Introduction to Japan MedTech Market
HekaBio is a unique platform for healthcare innovation in Japan, created by a diverse group of multicultural experts.
They invest in leading oncology, ophthalmology and cardiovascular innovations from around the world and accelerate commercialization in Japan.
About the speaker
Rob creates new businesses that address the unmet needs of patients, doctors, innovators, regulators and payors. He is passionate about developing innovative solutions for access to Japan’s healthcare market.
Over three decades, Rob has founded, managed and exited a number of healthcare businesses in Japan, Europe and the US including Junicon, a global healthcare marketing research consultancy that developed Japan’s first comprehensive Key Opinion Leader (KOL) physician database and pioneered in-hospital observational research, and Vorpal Technologies, a regulatory consultancy that achieved the leading position in Japan for new category MedTech approvals.
He maintains a worldwide trust network with leading innovators in MedTech and Pharma through optimism, tenacious follow-through and a spirit of collaboration.
Rob dedicates a part of his time to education and development as a Trustee of Yokohama International School and Board Chair of Hope International Development Agency Japan.
About ACCESS CHINA Boston Forum
“ACCESS CHINA – Boston Forum @BIO” is scheduled to be held on June 4th and June 13th-15th, 2023, in Boston and online, respectively. This event is expected to be the largest Asia-themed gathering during the BIO Convention 2023. The main theme of the forum is “Building Effective Partnerships in Asia: Strategies for Collaboration and Growth”. During the forum, we will cover a range of key topics include drug innovation, market trends, partnership models, and best practices for successful collaborations, etc.
Conference Name: ACCESS CHINA – Boston Forum @BIO
Date & Time: June 4, Sun. (Boston) and June 13-15 (Online)
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 1000 participants Online, 150 participants onsite; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs, investors.
View more information at https://biotochina.org/
“ACCESS CHINA 药通中国-波士顿论坛@BIO”将于2023年6月4-15日在波士顿及线上举行的。此次论坛将是BIO Convention 2023大会期间最大的亚洲主题交流活动。在过去3年时间，药通中国已成功举办13届线上线下活动，帮助近千家公司在药通平台上展出。
大会规模：预计线上1000参会者； 线下150参会者; 100场公司路演
Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact: